Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Arthralgia? 861 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 861 reports of Arthralgia have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.7% of all adverse event reports for CYCLOPHOSPHAMIDE.

861
Reports of Arthralgia with CYCLOPHOSPHAMIDE
0.7%
of all CYCLOPHOSPHAMIDE reports
71
Deaths
389
Hospitalizations

How Dangerous Is Arthralgia From CYCLOPHOSPHAMIDE?

Of the 861 reports, 71 (8.2%) resulted in death, 389 (45.2%) required hospitalization, and 92 (10.7%) were considered life-threatening.

Is Arthralgia Listed in the Official Label?

Yes, Arthralgia is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Arthralgia?

ADALIMUMAB (35,592) ETANERCEPT (27,429) METHOTREXATE (21,831) ABATACEPT (18,536) TOFACITINIB (15,640) TOCILIZUMAB (15,536) DUPILUMAB (15,176) SECUKINUMAB (13,769) INFLIXIMAB (13,441) RITUXIMAB (12,529)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Arthralgia Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Arthralgia Reports All Drugs Causing Arthralgia CYCLOPHOSPHAMIDE Demographics